Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$3.5M
5 rounds on record
Latest round
$3.5M
Venture round · Nov 2023 · 2 yr ago
Team
11-50
employees, estimated range
Grants
$1.9M
4 grants · CORDIS
Backers
1
Plug and Play
The money's age
Long since its last round
35 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Sep 5, 2024 Won a grant $325k · CORDIS Aug 14, 2024 New executive Jon Fernandez, Executive Officer · SEC Form D Mar 7, 2024 Won a grant $1.2M · CORDIS Dec 4, 2023 Board appointment Jim Kasic, Director · SEC Form D Nov 20, 2023 Raised a round Venture round $3.5M · SEC Form D May 1, 2023 Won a grant $75k · CORDIS Apr 24, 2023 Won a grant $300k · CORDIS 2020 Founded
Funding rounds
RoundDateAmountInvestorsSource
Grant Sep 2024 $325k — CORDIS
Grant Mar 2024 $1.2M — CORDIS
Venture round Nov 2023 $3.5M — SEC Form D
Grant May 2023 $75k — CORDIS
Grant Apr 2023 $300k — CORDIS
Registers and programsofficial lists and records that name the company
Legal entity GelSana Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Melissa KrebsExecutive Officer, DirectorSEC Form D
Jon FernandezExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Agrilogics Animal HealthVenture round $1M · 2 yr ago • Founded 2022 • 1-10 employees
Agrilogics Animal Health develops immune-based veterinary medical devices that support wound healing, incision care, and infection control…
MedicudVenture round $1.4M · 18 mo ago • 1-10 employees
Medicud develops sustainable negative pressure wound therapy devices to improve surgical healing and reduce environmental impact.
Nanordica Medical‘s first-in-class wound care products are designed to prevent infection and promote wound closure simultaneously.
Revolutionizing Wound Care with Advanced Hydrogel Technology.
Transforming Wound Care with Technology.
Aethl BioConvertible Note $1.6M · 15 mo ago • Founded 2025 • 51-200 employees
Aethl Bio exists to change how healing is defined and delivered. We.

Overview

We are Redefining Wound Healing Calming overactive inflammation with zwitterionic technology that kickstarts the body’s natural wound healing. CleraFlexTM.

People

Melissa Krebs
Executive Officer, Director
Jon Fernandez
Executive Officer
Mike Freeman
Director
Diana Verrilli
Director
Jim Kasic
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Aurora United States
HQ
12635 E Montview Blvd Ste. 326, Aurora, CO 80045
10-50 est. staff
12635 E Montview Blvd Ste. 326, Aurora, CO 80045
company site

Financials

Total raised
$5.4M
Latest round
Grant
Funding rounds
5
Funding rounds
Round Announced Amount
Grant 2024 $325k Details
Grant 2024 $1.2M Details
Venture - Series Unknown 2023 $3.5M Details
Grant 2023 $75k Details
Grant 2023 $300k Details